Skip to main content
Retour
Watch Compare

Nautilus Biotechnology, Inc.

Qualité des données : 83%
NAUT
Nasdaq Manufacturing Measuring & Analyzing Instruments
3,21 €
▲ 0,08 € (2,56%)
Cap. Boursière: 406,27 M
Prix
3,21 €
Cap. Boursière
406,27 M
Fourchette du Jour
3,10 € — 3,27 €
Fourchette 52 Semaines
0,62 € — 4,31 €
Volume
145 164
Ouverture 3,12 €
Moyenne 50J / 200J
2,63 €
22,03% above
Moyenne 50J / 200J
1,59 €
102,06% above

Quick Summary

Points Clés

Negative free cash flow of -51,97 M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-33,69%
Au-dessus de la moyenne du secteur (-53,47%)
ROICN/A
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio14,95
Interest CoverageN/A

Valorisation

PE (TTM)
-6,89
En dessous de la moyenne du secteur (-1,47)
P/B Ratio2,40
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E -6,9 -1,5
P/B 2,4 1,6
ROE % -33,7 -53,5
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -59,00 M
ROE -33,69% ROA -28,50%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -51,97 M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 14,95
Interest Coverage N/A Asset Turnover N/A
Working Capital 125,34 M Tangible Book Value 169,14 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -6,89 Forward P/E N/A
P/B Ratio 2,40 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -12,79%
Market Cap 406,27 M Enterprise Value 382,40 M
Per Share
EPS (Diluted TTM) -0,47 Revenue / Share N/A
FCF / Share -0,41 OCF / Share -0,40
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 88,09%
SBC-Adj. FCF -60,53 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2020
Revenue — — — — —
Net Income -59,00 M -70,78 M -63,68 M -57,92 M -523 083,0
EPS (Diluted) -0,47 -0,56 -0,51 -0,46 —
Gross Profit — — — — —
Operating Income — — — — -576 035,0
EBITDA — — — — —
R&D Expenses 41,11 M 50,48 M 47,25 M 37,67 M —
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense — — — — —
Income Tax 0,0 0,0 0,0 0,0 —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2020
Total Assets 191,11 M 242,74 M 305,57 M 350,05 M 150,86 M
Total Liabilities 34,14 M 34,01 M 40,21 M 35,13 M 5,62 M
Shareholders' Equity 156,97 M 208,73 M 265,35 M 314,92 M 5,00 M
Total Debt — — — — —
Cash & Equivalents 12,39 M 27,65 M 19,40 M 114,52 M —
Current Assets 105,96 M 132,83 M 176,84 M 187,21 M 1,30 M
Current Liabilities 7,95 M 7,63 M 9,12 M 6,79 M 388 507,0